Hormone therapy can reduce spread of cancer by a fifth
Women given the aromatase inhibitor exemestane after surgery were 19% less likely to suffer metastatic, or spreading, cancer than those receiving standard treatment.
Cancer is most deadly when it travels around the body, affecting vital organs such as the brain or liver.




